BioNTech SE (BNTX)
91.93
+1.80
(+2.00%)
USD |
NASDAQ |
May 09, 15:31
BioNTech Revenue (TTM): 2.954B for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.954B |
| December 31, 2023 | 4.122B |
| September 30, 2023 | 6.904B |
| June 30, 2023 | 9.416B |
| March 31, 2023 | 12.64B |
| December 31, 2022 | 18.42B |
| September 30, 2022 | 20.37B |
| June 30, 2022 | 24.06B |
| March 31, 2022 | 27.06B |
| December 31, 2021 | 22.37B |
| Date | Value |
|---|---|
| September 30, 2021 | 16.46B |
| June 30, 2021 | 9.357B |
| March 31, 2021 | 3.005B |
| December 31, 2020 | 567.25M |
| September 30, 2020 | 186.43M |
| June 30, 2020 | 139.37M |
| March 31, 2020 | 122.41M |
| December 31, 2019 | 121.55M |
| September 30, 2019 | 163.31M |
| June 30, 2019 | 155.16M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
121.55M
Minimum
Dec 2019
27.06B
Maximum
Mar 2022
8.929B
Average
5.513B
Median
Revenue (TTM) Benchmarks
| Pfizer Inc | 55.09B |
| Moderna Inc | 5.083B |
| Autolus Therapeutics PLC | -- |
| Novavax Inc | 693.46M |
| BioVie Inc | -- |